Brief: OptimizeRx Reports Q4 And Full Year 2021 Financial Results
Feb 24 (Reuters) - Optimizerx Corp OPRX.O :
* OPTIMIZERX REPORTS FOURTH QUARTER AND FULL YEAR 2021
FINANCIAL
RESULTS, REVENUE INCREASED 42%, DEMAND FROM LARGE PHARMA GAINS
MOMENTUM
* Q4 REVENUE ROSE 24 PERCENT TO $20.3 MILLION
* Q4 NON-GAAP EARNINGS PER SHARE $0.22
* FOR FULL YEAR 2022, COMPANY EXPECTS NET REVENUES OF $80
MILLION
TO $85 MILLION
* QTRLY EARNINGS PER SHARE $0.03
* Q4 EARNINGS PER SHARE VIEW $0.21, REVENUE VIEW $20.2
MILLION --
REFINITIV IBES DATA
Source text for Eikon: ID:nGNX6FG41C
Further company coverage: OPRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on OptimizeRx
See all newsBrief: Optimizerx Announces Finance Leadership Appointments To Support The Next Phase Of Growth
OptimizeRx Corporation reports results for the quarter ended June 30 - Earnings Summary
OptimizeRx Q2 revenue beats estimates on operating resilience; reaffirms outlook
OptimizeRx Corporation expected to post earnings of 12 cents a share - Earnings Preview
Brief: Optimizerx Corp - Enters Credit Agreement With Fifth Third Bank On May 7, 2026 - SEC Filing